Soleno Therapeutics, Inc. (SLNO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 25.98M | 48.7M | 43.63M | -12.61M | -32.75M | -23.99M | -14.93M | -17.65M | -12.53M | -6.31M | -6.33M | -5.57M | -6.73M | -5.14M | -4.66M | -4.62M | -6.36M | -6.86M | -5.41M | -8.01M |
| Operating CF Margin % | 27.46% | 53.1% | 66.09% | -38.61% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 179.32% | 303.01% | 392.32% | 28.57% | -161.43% | -279.97% | -135.72% | -217.12% | -86.21% | -22.77% | -36% | -20.48% | -5.75% | 25.06% | 13.87% | 42.34% | 15.04% | 0.06% | 12.3% | -22.64% |
| Net Income | 31.38M | 43.36M | 26.01M | -4.71M | -43.77M | -55.98M | -76.62M | -21.85M | -21.4M | -11.3M | -10.86M | -8.47M | -8.36M | -5.49M | -6.13M | -6.72M | -5.72M | -2.83M | -8.14M | -10.99M |
| Depreciation & Amortization | 514K | 509K | 502K | 502K | 504K | 503K | 500K | 494K | 490K | 489K | 490K | 489K | 490K | 488K | 492K | 492K | 492K | 492K | 492K | 490K |
| Stock-Based Compensation | 0 | 11.47M | 0 | 9.7M | 14.68M | 29.75M | 56.6M | 7.16M | 6.45M | 1.91M | 2.2M | 1.2M | 631K | 632K | 683K | 571K | 644K | 418K | 906K | 857K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.85M | 653K | -1K | 0 | 0 | 0 | 0 | 0 | -139K | -112K | -56K |
| Other Non-Cash Items | 16.45M | -219K | 10.56M | 317K | 2.19M | -876K | 2.49M | 593K | -4K | 3.53M | 1.09M | 406K | 393K | -524K | 202K | 686K | -816K | -3.26M | 620K | 3.11M |
| Working Capital Changes | -22.36M | -6.42M | 6.55M | -18.42M | -6.36M | 2.61M | 2.1M | -4.04M | 1.94M | 1.91M | 98K | 811K | 114K | -253K | 99K | 356K | -958K | -1.54M | 828K | -1.43M |
| Change in Receivables | -18.93M | -2.7M | -882K | -24.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -1.83M | -8.02M | -3.92M | -2.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.97M | 4.29M | 1.93M | 733K | -3.34M | 2.58M | 2.53M | -4.3M | 4.87M | 34K | -341K | 678K | 1M | -547K | -82K | 198K | -1.05M | -604K | 522K | -1.33M |
| Cash from Investing | 37.98M | -125.36M | -91.44M | -7.92M | 22.94M | 6.44M | 4.04M | -120.92M | -115.24M | 0 | 0 | 0 | 0 | -6K | -7K | -7K | 0 | -13K | -5K | 0 |
| Capital Expenditures | -40K | -58K | -1K | -9K | -5K | -8K | -191K | -8K | -11K | 0 | 0 | 0 | 0 | -6K | -7K | -7K | 0 | -13K | -5K | 0 |
| CapEx % of Revenue | 0.04% | 0.06% | 0% | 0.03% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -1.04M | -99.9M | 217.98M | 15.69M | 3.22M | 57.06M | 2.27M | 152.75M | 938K | 123.56M | 39.4M | 17.06M | 0 | 0 | 342K | -282K | 14.03M | -5K | 0 | 2K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K | 0 | 2K |
| Equity Issued (Net) | 48K | -99.19M | 217.98M | 15.9M | 0 | 0 | -637K | 0 | 0 | 117.92M | 2.87M | 17.06M | 0 | 1.04M | 342K | -282K | 14.05M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -4K | -100.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.09M | -708K | 0 | -211K | 3.22M | 57.06M | 2.91M | 152.75M | 938K | 5.63M | 36.53M | 0 | 0 | -1.04M | 0 | 0 | -16K | 0 | 0 | 0 |
| Net Change in Cash | 62.92M | -176.56M | 170.16M | -4.83M | -6.6M | 39.52M | -8.61M | 14.18M | -126.83M | 117.24M | 33.07M | 11.49M | -6.73M | -5.15M | -4.31M | -4.91M | 7.67M | -6.88M | -5.41M | -8.01M |
| Free Cash Flow | 25.94M | 48.65M | 43.63M | -12.62M | -32.76M | -24M | -15.12M | -17.66M | -12.54M | -6.31M | -6.33M | -5.57M | -6.73M | -5.15M | -4.66M | -4.63M | -6.36M | -6.88M | -5.41M | -8.01M |
| FCF Margin % | 27.42% | 53.03% | 66.09% | -38.63% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 179.19% | 302.7% | 388.62% | 28.55% | -161.24% | -280.09% | -138.74% | -217.27% | -86.37% | -22.63% | -35.79% | -20.29% | -5.75% | 25.12% | 13.82% | 42.26% | 15.08% | -0.07% | 12.26% | -22.64% |
| FCF per Share | 0.49 | 0.90 | 0.79 | -0.25 | -0.71 | -0.55 | -0.36 | -0.46 | -0.35 | -0.24 | -0.55 | -0.53 | -0.71 | -0.55 | -0.50 | -0.50 | -1.19 | -1.29 | -1.02 | -1.51 |
| FCF Conversion (FCF/Net Income) | 0.83x | 1.12x | 1.68x | 2.68x | 0.75x | 0.43x | 0.19x | 0.81x | 0.59x | 0.56x | 0.58x | 0.66x | 0.81x | 0.94x | 0.76x | 0.69x | 1.11x | 2.43x | 0.66x | 0.73x |
| Interest Paid | 0 | 0 | 0 | 0 | 805K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |